Two Sigma Investments, LP Allogene Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

  • $41.6 Billion
  • Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 2,712,139 shares of ALLO stock, worth $5.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,712,139
Previous 2,797,970 3.07%
Holding current value
$5.26 Million
Previous $7.83 Million 26.27%
% of portfolio
0.01%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$1.84 - $3.22 $157,929 - $276,375
-85,831 Reduced 3.07%
2,712,139 $5.78 Million
Q3 2024

Nov 14, 2024
SELL
$2.08 - $3.5 $338,422 - $569,460
-162,703 Reduced 5.5%
2,797,970 $7.83 Million
Q2 2024

Aug 14, 2024
BUY
$2.23 - $4.38 $2.34 Million - $4.6 Million
1,049,335 Added 54.9%
2,960,673 $6.9 Million
Q1 2024

May 15, 2024
SELL
$2.92 - $5.63 $1.18 Million - $2.27 Million
-403,203 Reduced 17.42%
1,911,338 $8.54 Million
Q4 2023

Feb 14, 2024
BUY
$2.28 - $3.5 $2.31 Million - $3.55 Million
1,014,320 Added 78.01%
2,314,541 $7.43 Million
Q3 2023

Nov 14, 2023
SELL
$3.17 - $5.96 $2.07 Million - $3.89 Million
-652,559 Reduced 33.42%
1,300,221 $4.12 Million
Q2 2023

Aug 14, 2023
BUY
$4.53 - $6.74 $344,420 - $512,448
76,031 Added 4.05%
1,952,780 $9.71 Million
Q1 2023

May 15, 2023
BUY
$4.92 - $8.21 $1.31 Million - $2.18 Million
265,497 Added 16.48%
1,876,749 $9.27 Million
Q4 2022

Feb 14, 2023
BUY
$5.62 - $11.11 $4.37 Million - $8.65 Million
778,288 Added 93.44%
1,611,252 $10.1 Million
Q3 2022

Nov 14, 2022
BUY
$10.32 - $17.28 $6.95 Million - $11.6 Million
673,886 Added 423.62%
832,964 $9 Million
Q2 2022

Aug 15, 2022
SELL
$6.78 - $12.28 $5.39 Million - $9.76 Million
-795,086 Reduced 83.33%
159,078 $1.81 Million
Q1 2022

May 16, 2022
BUY
$7.65 - $15.29 $5.85 Million - $11.7 Million
764,373 Added 402.74%
954,164 $8.69 Million
Q4 2021

Feb 14, 2022
BUY
$13.13 - $24.52 $2.49 Million - $4.65 Million
189,791 New
189,791 $2.83 Million
Q3 2021

Nov 15, 2021
SELL
$21.01 - $27.64 $658,852 - $866,762
-31,359 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$23.49 - $35.8 $3.79 Million - $5.77 Million
-161,179 Reduced 83.71%
31,359 $818,000
Q1 2021

May 17, 2021
SELL
$25.79 - $39.02 $3.9 Million - $5.9 Million
-151,086 Reduced 43.97%
192,538 $6.8 Million
Q4 2020

Feb 16, 2021
SELL
$25.24 - $43.45 $530,645 - $913,492
-21,024 Reduced 5.77%
343,624 $8.67 Million
Q3 2020

Nov 16, 2020
BUY
$32.38 - $44.96 $3.6 Million - $5 Million
111,255 Added 43.91%
364,648 $13.8 Million
Q2 2020

Aug 14, 2020
BUY
$18.39 - $54.04 $4.66 Million - $13.7 Million
253,393 New
253,393 $10.9 Million

Others Institutions Holding ALLO

# of Institutions
177
Shares Held
139M
Call Options Held
75.8K
Put Options Held
52.8K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $279M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email